Company Filing History:
10 out of 151 
1 out of 2,483 
1 out of 1,152 Years Active: 2013-2020
Title: The Innovative Contributions of Daniel Fleischanderl
Introduction
Daniel Fleischanderl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of continuous cell culture systems. With a total of six patents to his name, Fleischanderl's work has the potential to advance the production of important biological materials.
Latest Patents
One of Fleischanderl's latest patents is a method of producing a polypeptide or virus of interest in a continuous cell culture. This innovative approach describes a chemostat-like continuous cell culture system that combines the advantages of perfusion open systems and chemostat open systems. The system is designed to improve the culturing of mammalian cells, especially genetically modified cells, in serum-free or chemically-defined media. The method involves culturing mammalian cells in a continuous cell culture system that includes a cell retention device, with a dilution rate of less than about 2 d and a cell density of less than about 2×10 cells/mL. The process also includes recovering the polypeptide and/or virus of interest from the medium of the cell culture system.
Career Highlights
Fleischanderl has worked with prominent companies in the biotechnology sector, including Baxalta GmbH and Baxter International Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for cell culture and bioproduction.
Collaborations
Throughout his career, Fleischanderl has collaborated with notable colleagues such as Leopold Grillberger and Manfred Reiter. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Daniel Fleischanderl's contributions to biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in continuous cell culture systems and bioproduction techniques.